HEADER HYDROLASE 12-DEC-23 8RFB TITLE CRYO-EM STRUCTURE OF THE R243C MUTANT OF HUMAN PROLYL ENDOPEPTIDASE- TITLE 2 LIKE (PREPL) PROTEIN INVOLVED IN CONGENITAL MYASTHENIC SYNDROME-22 TITLE 3 (CMS22) COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROLYL ENDOPEPTIDASE-LIKE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: PROLYLENDOPEPTIDASE-LIKE; COMPND 5 EC: 3.4.21.-; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PREPL, KIAA0436; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS THIO-ESTERASE, HYDROLASE EXPDTA ELECTRON MICROSCOPY AUTHOR A.THEODOROPOULOU,E.CAVANI,A.ANTANASIJEVIC,M.J.MARCAIDA,M.DAL PERARO REVDAT 3 09-OCT-24 8RFB 1 REMARK REVDAT 2 18-SEP-24 8RFB 1 JRNL REVDAT 1 04-SEP-24 8RFB 0 JRNL AUTH Y.MONNENS,A.THEODOROPOULOU,K.ROSIER,K.BHALLA,A.MAHY, JRNL AUTH 2 R.VANHOUTTE,S.MEULEMANS,E.CAVANI,A.ANTANASIJEVIC,I.LEMMENS, JRNL AUTH 3 J.A.LEE,C.J.SPELLICY,R.J.SCHROER,R.A.MASELLI,C.G.LAVERTY, JRNL AUTH 4 P.AGOSTINIS,D.J.PAGLIARINI,S.VERHELST,M.J.MARCAIDA, JRNL AUTH 5 A.ROCHTUS,M.DAL PERARO,J.W.CREEMERS JRNL TITL MISSENSE VARIANTS IN CMS22 PATIENTS REVEAL THAT PREPL HAS JRNL TITL 2 BOTH ENZYMATIC AND NONENZYMATIC FUNCTIONS. JRNL REF JCI INSIGHT V. 9 2024 JRNL REFN ISSN 2379-3708 JRNL PMID 39078710 JRNL DOI 10.1172/JCI.INSIGHT.179276 REMARK 2 REMARK 2 RESOLUTION. 4.01 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : CRYOSPARC REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 4.010 REMARK 3 NUMBER OF PARTICLES : 137436 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 8RFB COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 12-DEC-23. REMARK 100 THE DEPOSITION ID IS D_1292135220. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : CRYOEM STRUCTURE OF THE R243C REMARK 245 MUTANT OF PROLYL ENDOPEPTIDASE- REMARK 245 LIKE (PREPL) PROTEIN REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : 13.00 REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.40 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : FEI FALCON IV (4K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 1500.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 2500.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 6000.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 28710 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 89 REMARK 465 MET A 90 REMARK 465 ASP A 91 REMARK 465 ALA A 92 REMARK 465 PHE A 93 REMARK 465 GLU A 94 REMARK 465 LYS A 95 REMARK 465 VAL A 96 REMARK 465 ARG A 97 REMARK 465 THR A 98 REMARK 465 LYS A 99 REMARK 465 LEU A 100 REMARK 465 GLU A 101 REMARK 465 THR A 102 REMARK 465 GLN A 103 REMARK 465 PRO A 104 REMARK 465 GLN A 105 REMARK 465 GLU A 106 REMARK 465 GLU A 107 REMARK 465 TYR A 108 REMARK 465 GLU A 109 REMARK 465 ILE A 110 REMARK 465 ASP A 134 REMARK 465 GLU A 135 REMARK 465 GLU A 136 REMARK 465 ALA A 137 REMARK 465 ASP A 138 REMARK 465 ASN A 139 REMARK 465 GLY A 687 REMARK 465 GLY A 688 REMARK 465 ASN A 689 REMARK 465 HIS A 690 REMARK 465 VAL A 691 REMARK 465 ILE A 692 REMARK 465 GLU A 693 REMARK 465 LEU A 721 REMARK 465 LYS A 722 REMARK 465 LYS A 723 REMARK 465 TYR A 724 REMARK 465 LEU A 725 REMARK 465 LYS A 726 REMARK 465 PHE A 727 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ILE A 111 CG1 CG2 CD1 REMARK 470 ASN A 112 CG OD1 ND2 REMARK 470 VAL A 113 CG1 CG2 REMARK 470 GLU A 114 CG CD OE1 OE2 REMARK 470 VAL A 115 CG1 CG2 REMARK 470 LYS A 116 CG CD CE NZ REMARK 470 ARG A 131 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 133 CG CD CE NZ REMARK 470 GLU A 143 CG CD OE1 OE2 REMARK 470 GLU A 149 CG CD OE1 OE2 REMARK 470 LEU A 151 CG CD1 CD2 REMARK 470 LYS A 152 CG CD CE NZ REMARK 470 ASP A 154 CG OD1 OD2 REMARK 470 GLN A 155 CG CD OE1 NE2 REMARK 470 ASP A 178 CG OD1 OD2 REMARK 470 LYS A 188 CG CD CE NZ REMARK 470 GLU A 206 CG CD OE1 OE2 REMARK 470 ASP A 213 CG OD1 OD2 REMARK 470 GLU A 214 CG CD OE1 OE2 REMARK 470 ARG A 232 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 239 CG CD CE NZ REMARK 470 ARG A 240 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 242 CG CD OE1 OE2 REMARK 470 LYS A 248 CG CD CE NZ REMARK 470 ARG A 306 CG CD NE CZ NH1 NH2 REMARK 470 ASP A 308 CG OD1 OD2 REMARK 470 GLU A 309 CG CD OE1 OE2 REMARK 470 GLU A 321 CG CD OE1 OE2 REMARK 470 LYS A 348 CG CD CE NZ REMARK 470 ASP A 353 CG OD1 OD2 REMARK 470 LYS A 421 CG CD CE NZ REMARK 470 LYS A 426 CG CD CE NZ REMARK 470 GLU A 430 CG CD OE1 OE2 REMARK 470 GLU A 434 CG CD OE1 OE2 REMARK 470 LYS A 463 CG CD CE NZ REMARK 470 ASP A 468 CG OD1 OD2 REMARK 470 ARG A 524 CG CD NE CZ NH1 NH2 REMARK 470 ASP A 534 CG OD1 OD2 REMARK 470 GLU A 536 CG CD OE1 OE2 REMARK 470 MET A 592 CG SD CE REMARK 470 MET A 593 CG SD CE REMARK 470 THR A 595 OG1 CG2 REMARK 470 GLU A 603 CG CD OE1 OE2 REMARK 470 GLU A 606 CG CD OE1 OE2 REMARK 470 GLU A 646 CG CD OE1 OE2 REMARK 470 ARG A 647 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 673 CG CD OE1 OE2 REMARK 470 LYS A 697 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 221 -168.22 -126.34 REMARK 500 ASN A 224 -161.77 69.13 REMARK 500 ARG A 240 -130.14 53.24 REMARK 500 SER A 284 74.23 -153.46 REMARK 500 ASP A 307 67.51 -155.79 REMARK 500 SER A 366 -122.31 58.30 REMARK 500 TYR A 479 -70.36 -122.25 REMARK 500 TYR A 482 18.87 58.99 REMARK 500 ARG A 524 -123.22 -125.95 REMARK 500 SER A 559 -108.12 47.12 REMARK 500 GLN A 632 -178.39 -173.13 REMARK 500 ASP A 713 -161.88 74.00 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 7OBM RELATED DB: PDB REMARK 900 RELATED ID: EMD-19117 RELATED DB: EMDB REMARK 900 CRYO-EM STRUCTURE OF THE R243C MUTANT OF HUMAN PROLYL ENDOPEPTIDASE- REMARK 900 LIKE (PREPL) PROTEIN INVOLVED IN CONGENITAL MYASTHENIC SYNDROME-22 REMARK 900 (CMS22) DBREF 8RFB A 90 727 UNP Q4J6C6 PPCEL_HUMAN 90 727 SEQADV 8RFB SER A 89 UNP Q4J6C6 EXPRESSION TAG SEQADV 8RFB CYS A 243 UNP Q4J6C6 ARG 243 ENGINEERED MUTATION SEQRES 1 A 639 SER MET ASP ALA PHE GLU LYS VAL ARG THR LYS LEU GLU SEQRES 2 A 639 THR GLN PRO GLN GLU GLU TYR GLU ILE ILE ASN VAL GLU SEQRES 3 A 639 VAL LYS HIS GLY GLY PHE VAL TYR TYR GLN GLU GLY CYS SEQRES 4 A 639 CYS LEU VAL ARG SER LYS ASP GLU GLU ALA ASP ASN ASP SEQRES 5 A 639 ASN TYR GLU VAL LEU PHE ASN LEU GLU GLU LEU LYS LEU SEQRES 6 A 639 ASP GLN PRO PHE ILE ASP CYS ILE ARG VAL ALA PRO ASP SEQRES 7 A 639 GLU LYS TYR VAL ALA ALA LYS ILE ARG THR GLU ASP SER SEQRES 8 A 639 GLU ALA SER THR CYS VAL ILE ILE LYS LEU SER ASP GLN SEQRES 9 A 639 PRO VAL MET GLU ALA SER PHE PRO ASN VAL SER SER PHE SEQRES 10 A 639 GLU TRP VAL LYS ASP GLU GLU ASP GLU ASP VAL LEU PHE SEQRES 11 A 639 TYR THR PHE GLN ARG ASN LEU ARG CYS HIS ASP VAL TYR SEQRES 12 A 639 ARG ALA THR PHE GLY ASP ASN LYS ARG ASN GLU CYS PHE SEQRES 13 A 639 TYR THR GLU LYS ASP PRO SER TYR PHE VAL PHE LEU TYR SEQRES 14 A 639 LEU THR LYS ASP SER ARG PHE LEU THR ILE ASN ILE MET SEQRES 15 A 639 ASN LYS THR THR SER GLU VAL TRP LEU ILE ASP GLY LEU SEQRES 16 A 639 SER PRO TRP ASP PRO PRO VAL LEU ILE GLN LYS ARG ILE SEQRES 17 A 639 HIS GLY VAL LEU TYR TYR VAL GLU HIS ARG ASP ASP GLU SEQRES 18 A 639 LEU TYR ILE LEU THR ASN VAL GLY GLU PRO THR GLU PHE SEQRES 19 A 639 LYS LEU MET ARG THR ALA ALA ASP THR PRO ALA ILE MET SEQRES 20 A 639 ASN TRP ASP LEU PHE PHE THR MET LYS ARG ASN THR LYS SEQRES 21 A 639 VAL ILE ASP LEU ASP MET PHE LYS ASP HIS CYS VAL LEU SEQRES 22 A 639 PHE LEU LYS HIS SER ASN LEU LEU TYR VAL ASN VAL ILE SEQRES 23 A 639 GLY LEU ALA ASP ASP SER VAL ARG SER LEU LYS LEU PRO SEQRES 24 A 639 PRO TRP ALA CYS GLY PHE ILE MET ASP THR ASN SER ASP SEQRES 25 A 639 PRO LYS ASN CYS PRO PHE GLN LEU CYS SER PRO ILE ARG SEQRES 26 A 639 PRO PRO LYS TYR TYR THR TYR LYS PHE ALA GLU GLY LYS SEQRES 27 A 639 LEU PHE GLU GLU THR GLY HIS GLU ASP PRO ILE THR LYS SEQRES 28 A 639 THR SER ARG VAL LEU ARG LEU GLU ALA LYS SER LYS ASP SEQRES 29 A 639 GLY LYS LEU VAL PRO MET THR VAL PHE HIS LYS THR ASP SEQRES 30 A 639 SER GLU ASP LEU GLN LYS LYS PRO LEU LEU VAL HIS VAL SEQRES 31 A 639 TYR GLY ALA TYR GLY MET ASP LEU LYS MET ASN PHE ARG SEQRES 32 A 639 PRO GLU ARG ARG VAL LEU VAL ASP ASP GLY TRP ILE LEU SEQRES 33 A 639 ALA TYR CYS HIS VAL ARG GLY GLY GLY GLU LEU GLY LEU SEQRES 34 A 639 GLN TRP HIS ALA ASP GLY ARG LEU THR LYS LYS LEU ASN SEQRES 35 A 639 GLY LEU ALA ASP LEU GLU ALA CYS ILE LYS THR LEU HIS SEQRES 36 A 639 GLY GLN GLY PHE SER GLN PRO SER LEU THR THR LEU THR SEQRES 37 A 639 ALA PHE SER ALA GLY GLY VAL LEU ALA GLY ALA LEU CYS SEQRES 38 A 639 ASN SER ASN PRO GLU LEU VAL ARG ALA VAL THR LEU GLU SEQRES 39 A 639 ALA PRO PHE LEU ASP VAL LEU ASN THR MET MET ASP THR SEQRES 40 A 639 THR LEU PRO LEU THR LEU GLU GLU LEU GLU GLU TRP GLY SEQRES 41 A 639 ASN PRO SER SER ASP GLU LYS HIS LYS ASN TYR ILE LYS SEQRES 42 A 639 ARG TYR CYS PRO TYR GLN ASN ILE LYS PRO GLN HIS TYR SEQRES 43 A 639 PRO SER ILE HIS ILE THR ALA TYR GLU ASN ASP GLU ARG SEQRES 44 A 639 VAL PRO LEU LYS GLY ILE VAL SER TYR THR GLU LYS LEU SEQRES 45 A 639 LYS GLU ALA ILE ALA GLU HIS ALA LYS ASP THR GLY GLU SEQRES 46 A 639 GLY TYR GLN THR PRO ASN ILE ILE LEU ASP ILE GLN PRO SEQRES 47 A 639 GLY GLY ASN HIS VAL ILE GLU ASP SER HIS LYS LYS ILE SEQRES 48 A 639 THR ALA GLN ILE LYS PHE LEU TYR GLU GLU LEU GLY LEU SEQRES 49 A 639 ASP SER THR SER VAL PHE GLU ASP LEU LYS LYS TYR LEU SEQRES 50 A 639 LYS PHE HELIX 1 AA1 GLU A 149 LYS A 152 5 4 HELIX 2 AA2 ALA A 333 TRP A 337 5 5 HELIX 3 AA3 PRO A 436 THR A 440 1 5 HELIX 4 AA4 ARG A 491 GLY A 501 1 11 HELIX 5 AA5 GLY A 516 ASP A 522 1 7 HELIX 6 AA6 LYS A 527 GLY A 546 1 20 HELIX 7 AA7 GLN A 549 SER A 551 5 3 HELIX 8 AA8 GLY A 561 ASN A 572 1 12 HELIX 9 AA9 PRO A 573 VAL A 576 5 4 HELIX 10 AB1 ASP A 587 MET A 593 1 7 HELIX 11 AB2 THR A 600 GLU A 605 1 6 HELIX 12 AB3 ASP A 613 CYS A 624 1 12 HELIX 13 AB4 PRO A 649 GLY A 672 1 24 HELIX 14 AB5 SER A 695 GLY A 711 1 17 SHEET 1 AA1 4 GLU A 114 HIS A 117 0 SHEET 2 AA1 4 PHE A 120 GLU A 125 -1 O TYR A 122 N VAL A 115 SHEET 3 AA1 4 CYS A 128 SER A 132 -1 O SER A 132 N VAL A 121 SHEET 4 AA1 4 TYR A 142 ASN A 147 -1 O GLU A 143 N ARG A 131 SHEET 1 AA2 4 PHE A 157 VAL A 163 0 SHEET 2 AA2 4 TYR A 169 ARG A 175 -1 O ARG A 175 N PHE A 157 SHEET 3 AA2 4 THR A 183 LYS A 188 -1 O VAL A 185 N ALA A 172 SHEET 4 AA2 4 MET A 195 PRO A 200 -1 O PHE A 199 N CYS A 184 SHEET 1 AA3 4 VAL A 202 LYS A 209 0 SHEET 2 AA3 4 ASP A 215 ARG A 223 -1 O PHE A 218 N GLU A 206 SHEET 3 AA3 4 CYS A 227 THR A 234 -1 O ALA A 233 N LEU A 217 SHEET 4 AA3 4 ARG A 240 THR A 246 -1 O PHE A 244 N VAL A 230 SHEET 1 AA4 4 PHE A 253 LEU A 258 0 SHEET 2 AA4 4 PHE A 264 MET A 270 -1 O THR A 266 N TYR A 257 SHEET 3 AA4 4 SER A 275 ASP A 281 -1 O TRP A 278 N ILE A 267 SHEET 4 AA4 4 VAL A 290 GLN A 293 -1 O VAL A 290 N LEU A 279 SHEET 1 AA5 4 TYR A 301 HIS A 305 0 SHEET 2 AA5 4 GLU A 309 THR A 314 -1 O TYR A 311 N GLU A 304 SHEET 3 AA5 4 LYS A 323 ALA A 328 -1 O MET A 325 N ILE A 312 SHEET 4 AA5 4 ASP A 338 THR A 342 -1 O PHE A 341 N LEU A 324 SHEET 1 AA6 4 LYS A 348 MET A 354 0 SHEET 2 AA6 4 HIS A 358 HIS A 365 -1 O LYS A 364 N LYS A 348 SHEET 3 AA6 4 LEU A 368 GLY A 375 -1 O ASN A 372 N LEU A 361 SHEET 4 AA6 4 VAL A 381 SER A 383 -1 O ARG A 382 N VAL A 373 SHEET 1 AA7 3 GLY A 392 MET A 395 0 SHEET 2 AA7 3 CYS A 404 SER A 410 -1 O GLN A 407 N ILE A 394 SHEET 3 AA7 3 ARG A 413 TYR A 420 -1 O TYR A 418 N PHE A 406 SHEET 1 AA8 8 SER A 441 ARG A 445 0 SHEET 2 AA8 8 MET A 458 LYS A 463 -1 O HIS A 462 N ARG A 442 SHEET 3 AA8 8 ILE A 503 CYS A 507 -1 O LEU A 504 N PHE A 461 SHEET 4 AA8 8 LEU A 474 VAL A 478 1 N LEU A 475 O ALA A 505 SHEET 5 AA8 8 THR A 553 PHE A 558 1 O THR A 554 N LEU A 474 SHEET 6 AA8 8 ALA A 578 GLU A 582 1 O THR A 580 N LEU A 555 SHEET 7 AA8 8 SER A 636 TYR A 642 1 O SER A 636 N VAL A 579 SHEET 8 AA8 8 ILE A 680 GLN A 685 1 O ILE A 681 N ILE A 639 SHEET 1 AA9 2 ALA A 448 LYS A 449 0 SHEET 2 AA9 2 LEU A 455 VAL A 456 -1 O VAL A 456 N ALA A 448 SSBOND 1 MET A 458 CYS A 538 1555 1555 2.10 SSBOND 2 CYS A 507 CYS A 538 1555 1555 2.67 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000